Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII

The signaling output of protein kinase C (PKC) is exquisitely controlled, with its disruption resulting in pathophysiologies. Identifying the structural basis for autoinhibition is central to developing effective therapies for cancer, where PKC activity needs to be enhanced, or neurodegenerative dis...

Full description

Bibliographic Details
Main Authors: Corina E. Antal, Julia A. Callender, Alexandr P. Kornev, Susan S. Taylor, Alexandra C. Newton
Format: Article
Language:English
Published: Elsevier 2015-08-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124715007998
_version_ 1819231677341237248
author Corina E. Antal
Julia A. Callender
Alexandr P. Kornev
Susan S. Taylor
Alexandra C. Newton
author_facet Corina E. Antal
Julia A. Callender
Alexandr P. Kornev
Susan S. Taylor
Alexandra C. Newton
author_sort Corina E. Antal
collection DOAJ
description The signaling output of protein kinase C (PKC) is exquisitely controlled, with its disruption resulting in pathophysiologies. Identifying the structural basis for autoinhibition is central to developing effective therapies for cancer, where PKC activity needs to be enhanced, or neurodegenerative diseases, where PKC activity should be inhibited. Here, we reinterpret a previously reported crystal structure of PKCβII and use docking and functional analysis to propose an alternative structure that is consistent with previous literature on PKC regulation. Mutagenesis of predicted contact residues establishes that the Ca2+-sensing C2 domain interacts intramolecularly with the kinase domain and the carboxyl-terminal tail, locking PKC in an inactive conformation. Ca2+-dependent bridging of the C2 domain to membranes provides the first step in activating PKC via conformational selection. Although the placement of the C1 domains remains to be determined, elucidation of the structural basis for autoinhibition of PKCβII unveils a unique direction for therapeutically targeting PKC.
first_indexed 2024-12-23T11:48:46Z
format Article
id doaj.art-c650f394c8d446f09707acf389c72e84
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-23T11:48:46Z
publishDate 2015-08-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-c650f394c8d446f09707acf389c72e842022-12-21T17:48:17ZengElsevierCell Reports2211-12472015-08-011281252126010.1016/j.celrep.2015.07.039Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βIICorina E. Antal0Julia A. Callender1Alexandr P. Kornev2Susan S. Taylor3Alexandra C. Newton4Department of Pharmacology, University of California at San Diego, La Jolla, CA 92037, USADepartment of Pharmacology, University of California at San Diego, La Jolla, CA 92037, USADepartment of Pharmacology, University of California at San Diego, La Jolla, CA 92037, USADepartment of Pharmacology, University of California at San Diego, La Jolla, CA 92037, USADepartment of Pharmacology, University of California at San Diego, La Jolla, CA 92037, USAThe signaling output of protein kinase C (PKC) is exquisitely controlled, with its disruption resulting in pathophysiologies. Identifying the structural basis for autoinhibition is central to developing effective therapies for cancer, where PKC activity needs to be enhanced, or neurodegenerative diseases, where PKC activity should be inhibited. Here, we reinterpret a previously reported crystal structure of PKCβII and use docking and functional analysis to propose an alternative structure that is consistent with previous literature on PKC regulation. Mutagenesis of predicted contact residues establishes that the Ca2+-sensing C2 domain interacts intramolecularly with the kinase domain and the carboxyl-terminal tail, locking PKC in an inactive conformation. Ca2+-dependent bridging of the C2 domain to membranes provides the first step in activating PKC via conformational selection. Although the placement of the C1 domains remains to be determined, elucidation of the structural basis for autoinhibition of PKCβII unveils a unique direction for therapeutically targeting PKC.http://www.sciencedirect.com/science/article/pii/S2211124715007998
spellingShingle Corina E. Antal
Julia A. Callender
Alexandr P. Kornev
Susan S. Taylor
Alexandra C. Newton
Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII
Cell Reports
title Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII
title_full Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII
title_fullStr Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII
title_full_unstemmed Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII
title_short Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII
title_sort intramolecular c2 domain mediated autoinhibition of protein kinase c βii
url http://www.sciencedirect.com/science/article/pii/S2211124715007998
work_keys_str_mv AT corinaeantal intramolecularc2domainmediatedautoinhibitionofproteinkinasecbii
AT juliaacallender intramolecularc2domainmediatedautoinhibitionofproteinkinasecbii
AT alexandrpkornev intramolecularc2domainmediatedautoinhibitionofproteinkinasecbii
AT susanstaylor intramolecularc2domainmediatedautoinhibitionofproteinkinasecbii
AT alexandracnewton intramolecularc2domainmediatedautoinhibitionofproteinkinasecbii